Discussion about this post

User's avatar
Sudeep Bansal, MD, MS's avatar

Thank you posting the problems related to quality measurement. I run my medical practice, have worked in value based care and currently in vbc contracts. I agree with the problems with data collection and insurance companies hold most of the cards when submitting supplementary data to prove that we took care of patients. Incidentally.

I do disagree about cancer screening saving money down the road. JAMA published an article that cancer screening does not decrease all cause mortality. Annals of IM published another article that the cost of annual screenings in $43billion mostly driven by colonoscopy (and this does not capture any follow up cost). The data for colonoscopy is based on observational data and the only RCT (NORDIIC trial) did not show any benefit in people invited for colonoscopy.

Besides data collection issue, this creates a bias “for” screening. If we tell people about the NORDIIC trial, several people may choose not to undergo colonoscopy and that penalizes the primary care doctor (I am not against screening, I think people should make an informed decision).

As an independant primary care physician, I am trying to raise awareness about the financialization of medicine on my website www.PCPLens.com.

Looking forward to reading more of your articles.

Expand full comment
David Roberts's avatar

When you discretize continuous phenomena...

Expand full comment

No posts